# FDA Warning Letter: AcelRx Pharmaceuticals, Inc.
> 2021-02-16 · The Office of Prescription Drug Promotion (OPDP) · `e5365a221ae238cd`
## Letter
- **Company:** AcelRx Pharmaceuticals, Inc.
- **Posted Date:** 2021-02-16
- **Letter Issue Date:** 2021-02-11
- **Issuing Office:** The Office of Prescription Drug Promotion (OPDP)
## Subject
False & Misleading Claims/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*